- Home
- News
All News
-
Paper: Rejuvenation of aged immune cells improves PD-1 blockade cancer immunotherapy
Although aging is known to suppress antitumor immunity, the precise underlying mechanism remains largely unknown. A new paper now explains why aging may be relevant to cancer immunity and immunotherapy.
More
-
UBC honorary degree for Professor Tasuku Honjo
CCII Founding Director Tasuku Honjo is awarded a honorary degree by the University of British Columbia, Canada.
More
-
Cancer Immunotherapy Research Fund launched
Kyoto University established a new research fund to support research in cancer immunotherapy.
More
-
[CLOSED] Call for Applications: Associate Professor Position within the Metabolome Platform Team
This Call for Applications is now closed, but we are permanently recruiting. Please contact us!
More
-
Start of the Construction of the BMS Building
The work to construct CCII's new research building, located at the main campus of the Kyoto University medical school, has officially started.
More